The Use of Targeted Therapies for Precision Medicine in Oncology.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Nicole
N
White Al-Habeeb
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.|Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada.
Vathany
V
Kulasingam
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; eleftherios.diamandis@sinaihealthsystem.ca.|Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada.|Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
Eleftherios P
EP
Diamandis
Division Head, Molecular Diagnostics, Department of Laboratory Medicine, St. Michael's Hospital, Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.
George M
GM
Yousef
Professor and Director, Clinical Genomics and Advanced Technology (CGAT), Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center and Geisel School of Medicine, Lebanon, NH.
Gregory J
GJ
Tsongalis
Principal Investigator, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands.
Louis
L
Vermeulen
Physician, Department of Medicine, The Brookdale University Hospital and Medical Center, Brooklyn, NY.
Ziqiang
Z
Zhu
Chief, Clinical Laboratory Genetics, University Health Network, Professor, University of Toronto, Canada.
Suzanne
S
Kamel-Reid
D017048:Health Care Costs; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000503:physiopathology; D057285:Precision Medicine / Q000191:economics; D011788:Quality of Life; D016019:Survival Analysis